Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2010-05-17

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1073/pnas.1001412107PMID 20479234PMCID PMC2890481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Apolipoprotein E4 and Sex Affect Neurobehavioral Performance in Primary School Children

  2010cited by this paper
• Positive Effects of Cholinergic Stimulation Favor Young APOE ɛ4 Carriers

  2010cited by this paper
• Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies

  2010cited by this paper
• Mapping the effect of APOE ε4 on gray matter loss in Alzheimer's disease in vivo

  2009cited by this paper
• An MRI-based method for measuring volume, thickness and surface area of entorhinal, perirhinal, and posterior parahippocampal cortex.

  2009cited by this paper
• With or without FUS, it is the anatomy that dictates the dementia phenotype.

  2009cited by this paper
• Apolipoprotein E ε4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia

  2009cited by this paper
• Differential effects of aging and Alzheimer's disease on medial temporal lobe cortical thickness and surface area.

  2009cited by this paper
• Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease

  2009cited by this paper
• Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

  2009cited by this paper
• Anatomically-distinct genetic associations of APOE ɛ4 allele load with regional cortical atrophy in Alzheimer's disease

  2009cited by this paper
• The cortical signature of prodromal AD

  2009influential reference
• Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes

  2008cited by this paper
• Primary progressive aphasia pathology

  2008cited by this paper
• Alzheimer's Disease Neuroimaging Initiative

  2008cited by this paper
• Evidence for a frontoparietal control system revealed by intrinsic functional connectivity.

  2008cited by this paper
• The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals

  2008cited by this paper
• Variability in cognitive presentation of Alzheimer's disease.

  2008cited by this paper
• Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengths

  2008cited by this paper
• The Search for the Phonological Store: From Loop to Convolution

  2008cited by this paper
• Cognitive Impairment in Alzheimer’s Disease Is Modified by APOE Genotype

  2007cited by this paper
• Distinct memory profiles in Alzheimer's disease.

  2007cited by this paper
• Focal cortical presentations of Alzheimer's disease.

  2007cited by this paper
• The entorhinal cortex: an anatomical mediator of genetic vulnerability to Alzheimer's disease?

  2007cited by this paper
• Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study.

  2007cited by this paper
• Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

  2007cited by this paper
• アルツハイマー病の早期診断に向けて-米国 Alzheimer's Disease Neuroimaging Initiative の取り組み

  2006influential reference
• Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

  2006cited by this paper
• APOE related alterations in cerebral activation even at college age

  2005cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice

  2004cited by this paper
• Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.

  2004cited by this paper
• Apolipoprotein E ε4 Allele Differently Affects the Patterns of Neuropsychological Presentation in Early- and Late-Onset Alzheimer’s Disease Patients

  2004cited by this paper
• Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice

  2003cited by this paper
• California Verbal Learning Test: performance by patients with focal frontal and non-frontal lesions.

  2003cited by this paper
• Control of goal-directed and stimulus-driven attention in the brain

  2002cited by this paper
• Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.

  2001influential reference
• Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer’s disease

  2001cited by this paper
• Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers.

  2000cited by this paper
• Intelligence and event-related potentials for young female human volunteer apolipoprotein E ε4 and non-ε4 carriers

  2000cited by this paper
• Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.

  2000cited by this paper
• Short-term memory deficit after focal parietal damage.

  1999cited by this paper
• Apolipoprotein E and β-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent

  1999cited by this paper
• Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia

  1999cited by this paper
• APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD

  1999cited by this paper
• Clinical and pathological evidence for a frontal variant of Alzheimer disease.

  1999cited by this paper
• APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.

  1999cited by this paper
• Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer's disease but not in healthy control subjects

  1998cited by this paper
• Major decrease in the volume of the entorhinal cortex in patients with Alzheimer’s disease carrying the apolipoprotein E ε4 allele

  1998cited by this paper
• Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease

  1998cited by this paper
• Relating anatomy to function in Alzheimer's disease

  1998cited by this paper
• Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease

  1996cited by this paper
• Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.

  1995cited by this paper
• Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes.

  1995cited by this paper
• Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype

  1994cited by this paper
• Apolipoprotein E polymorphism and Alzheimer's disease.

  1993cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Longitudinal analysis of a two-component model of the memory deficit in Alzheimer's disease

  1992cited by this paper
• The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.

  1991cited by this paper
• The two-component hypothesis of memory deficit in Alzheimer's disease.

  1991cited by this paper
• Balint's syndrome in Alzheimer's disease: specific disruption of the occipito-parietal visual pathway.

  1989cited by this paper
• Pragmatics of measuring recognition memory: applications to dementia and amnesia.

  1988cited by this paper
• Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

  1988cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Short- and long-term memory in patients with presenile dementia (Alzheimer's disease)

  1973cited by this paper
• Please Scroll down for Article the Quarterly Journal of Experimental Psychology Independent Functioning of Verbal Memory Stores: a Neuropsychological Study Independent Functioning of Verbal Memory Stores : a Neuropsychological Study

  year unknowncited by this paper

• The apolipoprotein gene: A modulating role on brain volume and cognitive function in carriers of the fragile X premutation.

  2026cites this paper
• Interactive Effects of APOE ε4 and Amyloid-β on Cerebrospinal Fluid Biomarkers, Hippocampal Atrophy, and Cognitive Decline in Individuals with Mild Cognitive Impairment

  2025cites this paper
• Multimodal Imaging Markers of Cognitive Resilience and Molecular Mechanisms of Brain Resilience in Alzheimer's Disease.

  2025cites this paper
• Concurrent detection of cognitive impairment and amyloid positivity with a multimodal machine learning-enabled digital cognitive assessment

  2025cites this paper
• Vulnerability to memory decline in aging – a mega-analysis of structural brain change

  2025cites this paper
• Kinematic correlates of early speech motor changes in cognitively intact APOE-ε4 carriers: a preliminary study using a color-word interference task

  2025cites this paper
• Vulnerability to memory decline in aging revealed by a mega-analysis of structural brain change

  2025cites this paper
• Multiple Bio-Computational Tools Emerge as Valid Approach in the Assessment of Apolipoproteins Pathogenicity Related Mutations

  2025cites this paper
• Kinematic Correlates of Early Speech Motor Changes in Cognitively Intact APOE-ε4 Carriers: A Preliminary Study Using a Color-Word Interference Task

  2025cites this paper
• Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer’s disease: a neuropsychological data-driven approach

  2025cites this paper
• The association of human apolipoprotein ε4 with dementia, cognition, imaging, and plasma biomarkers of neurodegeneration in a sample of older adults in the Democratic Republic of the Congo

  2025cites this paper
• Integrating imaging and genetic data via wavelet transform-based CNN for Alzheimer 's disease classification

  2025cites this paper
• Role of tau versus TDP‐43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease

  2025cites this paper
• APOE ε4 carriage associates with improved myocardial performance from adolescence to older age

  2024cites this paper
• Exploring the impact of APOE ɛ4 on functional connectivity in Alzheimer's disease across cognitive impairment levels

  2024cites this paper
• The impact of APOE ε4 in Alzheimer’s disease: a meta-analysis of voxel-based morphometry studies

  2024cites this paper
• Dynamic reconfiguration of brain coactivation states that underlying working memory correlates with cognitive decline in clinically unimpaired older adults.

  2024cites this paper
• Effects of a high-fat diet on cognition and brain distribution of intranasal insulin in E3 and E4 male and female mice

  2024cites this paper
• Impact of Apolipoprotein E ε4 in Alzheimer’s Disease: A Meta-Analysis of Voxel-Based Morphometry Studies

  2024cites this paper
• APOEε4 Carriers Exhibit Objective Cognitive Deficits: A Cross-Sectional Study in a Single Center Trial

  2024influential citation
• Neuropathology-Independent Association Between APOE Genotype and Cognitive Decline Rate in the Normal Aging-Early Alzheimer Continuum

  2023cites this paper
• Exploring the parity paradox: Differential effects on neuroplasticity and neuroinflammation by APOEe4 genotype at middle-age

  2023cites this paper
• Role of nerve growth factor on cognitive impairment in patients with Alzheimer's disease carrying apolipoprotein E ε4

  2023cites this paper
• The roles of apolipoprotein E ε4 on neuropathology and neuroinflammation in patients with Alzheimer's disease

  2023cites this paper
• Higher Neuronal Facilitation and Potentiation with APOE4 Suppressed by Angiotensin II

  2023cites this paper
• Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults

  2023cites this paper
• Evaluation of the NIH Toolbox Odor Identification Test across normal cognition, amnestic mild cognitive impairment, and dementia due to Alzheimer's disease

  2023cites this paper
• How Many Alzheimer–Perusini’s Atypical Forms Do We Still Have to Discover?

  2023cites this paper
• The relation of ApoE and COMT gene–gene interactions to cognitive and motor function in community-dwelling older adults: a pilot study

  2023cites this paper
• FDG‐PET markers of heterogeneity and different risk of progression in amnestic MCI

  2023cites this paper
• IMPACT OF DYSEXECUTIVE SYNDROME IN QUALITY OF LIFE IN ALZHEIMER DISEASE: WHAT WE KNOW NOW AND WHERE WE ARE HEADED.

  2023cites this paper
• Shared and unique effects of ApoEε4 and pathogenic gene mutation on cognition and imaging in preclinical familial Alzheimer’s disease

  2023cites this paper
• Association of Performance on Olfactory and Cognitive Screening Tests With Conversion to Dementia in a Biracial Cohort of Older Adults

  2023cites this paper
• Frontal variant Alzheimer's disease: A systematic narrative synthesis.

  2023cites this paper
• APOE ε4 carriage associates with improved myocardial performance in older age

  2022cites this paper
• Accounting for iron-related off-target binding effects of 18F-AV1451 PET in the evaluation of cognition and microstructure in APOE-e4+ MCI

  2022cites this paper
• Episodic memory dysfunction and hypersynchrony in brain functional networks in cognitively intact subjects and MCI: a study of 379 individuals

  2022cites this paper
• Limbic-Predominant Age-Related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers

  2022cites this paper
• Differences in resting state functional connectivity underlie visuomotor performance declines in older adults with a genetic risk (APOE ε4) for Alzheimer’s disease

  2022cites this paper
• Regional A b -tau interactions promote onset and acceleration of Alzheimer’s disease tau spreading

  2022cites this paper
• APOE ε 4 carriage associates with improved myocardial performance in older age

  2022cites this paper
• Distinct Effects of the Apolipoprotein E ε4 Genotype on Associations Between Delayed Recall Performance and Resting-State Electroencephalography Theta Power in Elderly People Without Dementia

  2022cites this paper
• Regional Aβ-tau interactions promote onset and acceleration of Alzheimer's disease tau spreading.

  2022cites this paper
• Virtual reality cognitive intervention for heart failure: CORE study protocol

  2022cites this paper
• White matter hyperintensities and longitudinal cognitive decline in cognitively normal populations and across diagnostic categories: A meta‐analysis, systematic review, and recommendations for future study harmonization

  2022cites this paper
• A review of brain imaging biomarker genomics in Alzheimer’s disease: implementation and perspectives

  2022cites this paper
• Joint trajectories of episodic memory and odor identification in older adults: patterns and predictors

  2021cites this paper
• Topographical patterns of whole-brain structural alterations in association with genetic risk, cerebrospinal fluid, positron emission tomography biomarkers of Alzheimer’s disease, and neuropsychological measures

  2021cites this paper
• The human connectome in Alzheimer disease — relationship to biomarkers and genetics

  2021cites this paper
• The APOE ε4 variant and hippocampal atrophy in Alzheimer’s disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance

  2021influential citation
• Effects of apolipoprotein E isoform, sex, and diet on insulin BBB pharmacokinetics in mice

  2021cites this paper
• Genetic Insights into Alzheimer's Disease.

  2021cites this paper
• Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy

  2021cites this paper
• Different posterior hippocampus and default mode network modulation in young APOE ε4 carriers: a functional connectome-informed phenotype longitudinal study

  2021cites this paper
• Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease

  2021cites this paper
• Resilience to Plasma and Cerebrospinal Fluid Amyloid-β in Cognitively Normal Individuals: Findings From Two Cohort Studies

  2021cites this paper
• Apolipoprotein E genotype and MRI-detected brain alterations pertaining to neurodegeneration: A systematic review

  2021cites this paper
• The APOE ε4 Allele Affects Cognitive Functions Differently in Carriers of APP Mutations Compared to Carriers of PSEN1 Mutations in Autosomal-Dominant Alzheimer’s Disease

  2021cites this paper
• Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnoses.

  2021cites this paper
• APOE, TOMM40, and Sex Interactions on Neural Network Connectivity

  2021cites this paper
• Sex and sex hormone differences in hippocampal neurogenesis and their relevance to Alzheimer’s disease

  2021cites this paper
• Modulation of motor cortical excitability by continuous theta-burst stimulation in adults with autism spectrum disorder.

  2021cites this paper
• Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer’s and Lewy body neuropathology

  2021cites this paper
• Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods.

  2020cites this paper
• Oral health & olfactory function : what can they tell us about cognitive ageing?

  2020cites this paper
• APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review

  2020cites this paper
• Non‐memory cognitive symptom development in Alzheimer's disease

  2020cites this paper
• Nonlinear interaction between APOE ε4 allele load and age in the hippocampal surface of cognitively intact individuals

  2020cites this paper
• Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease

  2020cites this paper
• APOE Genotypes and Brain Imaging Classes in Normal Cognition, Mild Cognitive Impairment, and Alzheimer's Disease: a Longitudinal Study.

  2020cites this paper
• Longitudinal association between hippocampus atrophy and episodic‐memory decline in non‐demented APOE ε4 carriers

  2020cites this paper
• Benefit of phonemic cueing on confrontation naming in Alzheimer's disease

  2020cites this paper
• Short-term memory advantage for brief durations in human APOE ε4 carriers

  2020cites this paper
• Modulation of motor cortical excitability by continuous theta-burst stimulation in adults with autism spectrum disorder: The roles of BDNF and APOE polymorphisms

  2020cites this paper
• Frontal-executive and corticolimbic structural brain circuitry in older people with remitted depression, mild cognitive impairment, Alzheimer’s dementia, and normal cognition

  2020cites this paper
• Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease

  2020cites this paper
• Progressive dysexecutive syndrome due to Alzheimer’s disease: a description of 55 cases and comparison to other phenotypes

  2020cites this paper
• The effect of ApoE ε 4 on clinical and structural MRI markers in prodromal Alzheimer's disease.

  2020cites this paper
• Memory precision of object-location binding is unimpaired in APOE ε4-carriers with spatial navigation deficits

  2020cites this paper
• Cross-sectional and longitudinal medial temporal lobe subregional atrophy patterns in semantic variant primary progressive aphasia.

  2020cites this paper
• Risk Factors Predicting Amyloid PET Positivity in Patients with Mild Cognitive Impairment and Apolipoprotein E ɛ3/ɛ3 Genotypes

  2020cites this paper
• Superior short-term memory in APOE ε2 carriers across the age range

  2020cites this paper
• APOE ε4 and cognitive reserve effects on the functional network in the Alzheimer’s disease spectrum

  2020cites this paper
• A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease

  2019cites this paper
• Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.

  2019cites this paper
• Interaction Between Odor Identification Deficit and APOE4 Predicts 6-Year Cognitive Decline in Elderly Individuals

  2019cites this paper
• Fractionating the Rey Auditory Verbal Learning Test: Distinct roles of large-scale cortical networks in prodromal Alzheimer's disease.

  2019cites this paper
• The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum

  2019cites this paper
• APOE ɛ4 Carriers Show Delayed Recovery of Verbal Memory and Smaller Entorhinal Volume in the First Year After Ischemic Stroke

  2019cites this paper
• The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk

  2019cites this paper
• Clinical and genetic heterogeneity in young onset sporadic Alzheimer's disease

  2019cites this paper
• APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort

  2019cites this paper
• ERα Gene Promoter Methylation in Cognitive Function and Quality of Life of Patients With Alzheimer Disease

  2019cites this paper
• Integrating Neuroimaging and Genetics Data in a Bioinformatics-based Approach for the Study of Alzheimer’s Disease

  2019cites this paper
• Default Mode Network Connectivity Moderates the Relationship Between the APOE Genotype and Cognition and Individualizes Identification Across the Alzheimer’s Disease Spectrum

  2019cites this paper
• Working Memory in Alzheimer's Disease and Parkinson's Disease.

  2019cites this paper
• Cognitive Performance in Young APOE ε4 Carriers: A Latent Variable Approach for Assessing the Genotype–Phenotype Relationship

  2019cites this paper
• APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points

  2019cites this paper
• Dissociable effects of the apolipoprotein-E (APOE) gene on short- and long-term memories

  2019cites this paper
• The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study

  2019cites this paper